20Q CHROMOSOME DELETION (MDS) / HEPARIN BONE MARROW

image not found

The 20q Chromosome Deletion (MDS) Test using heparinized bone marrow at Metropolis Healthcare identifies the loss of genetic material on the long arm (q) of chromosome 20, a key abnormality in myelodysplastic syndromes (MDS) and related bone marrow disorders. Detecting this deletion helps in assessing disease severity, prognosis, and response to treatment. The test provides crucial insights for risk classification and clinical decision-making. It assists doctors in planning targeted and personalized therapies. Metropolis Healthcare ensures high accuracy with advanced cytogenetic testing methods.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 5,195.00

Sample Type: HEPARIN BONE MARROW

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
  4. Soft copy reports will be sent to your email address within 24 to 48 hours.

Frequently Asked Questions (FAQ's):

1. What is the 20q Chromosome Deletion (MDS) Test using heparinized bone marrow?
This test detects the deletion on the long arm (q) of chromosome 20 in patients with myelodysplastic syndromes (MDS) using a heparin-treated bone marrow sample.

2. Why is this test important?
It helps determine genetic abnormalities associated with MDS, which are essential for accurate diagnosis, prognosis, and treatment planning.

3. Who should undergo this test?
Patients with confirmed or suspected MDS or bone marrow disorders may be recommended this test for genetic evaluation.

4. How is the test performed?
At Metropolis Healthcare, a heparinized bone marrow sample is collected and analyzed using advanced cytogenetic and molecular techniques to detect chromosome deletions.

5. What do the results indicate?
The detection of a 20q deletion suggests a genetic alteration linked to MDS, assisting doctors in disease staging and therapy management.

6. Are there any risks associated with the test?
The test is safe, with minimal discomfort related to bone marrow sample collection.

7. Why choose Metropolis Healthcare for this test?
Metropolis Healthcare offers precise cytogenetic testing, expert pathologist interpretation, and cutting-edge technology to ensure reliable results for the effective diagnosis and management of MDS.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab